| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 14 | 2024 | 522 | 3.260 |
Why?
|
| Endothelium, Vascular | 11 | 2021 | 520 | 2.870 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 6 | 2021 | 31 | 2.030 |
Why?
|
| Carrier Proteins | 7 | 2021 | 1022 | 1.600 |
Why?
|
| Receptors, LDL | 3 | 2017 | 87 | 1.420 |
Why?
|
| Signal Transduction | 18 | 2024 | 4504 | 1.240 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 464 | 1.190 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 5 | 2021 | 23 | 1.120 |
Why?
|
| Neovascularization, Physiologic | 6 | 2014 | 209 | 1.110 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 62 | 1.110 |
Why?
|
| Cell Movement | 9 | 2018 | 835 | 0.900 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 32 | 0.770 |
Why?
|
| Hyperglycemia | 2 | 2021 | 222 | 0.750 |
Why?
|
| Osteocalcin | 1 | 2021 | 42 | 0.750 |
Why?
|
| Capillary Permeability | 2 | 2018 | 75 | 0.740 |
Why?
|
| Procollagen-Proline Dioxygenase | 5 | 2021 | 36 | 0.690 |
Why?
|
| Mice, Knockout | 13 | 2024 | 3727 | 0.650 |
Why?
|
| HEK293 Cells | 5 | 2021 | 744 | 0.610 |
Why?
|
| Insulin Resistance | 2 | 2021 | 637 | 0.600 |
Why?
|
| Vasculitis | 1 | 2018 | 49 | 0.600 |
Why?
|
| Cells, Cultured | 14 | 2024 | 3038 | 0.580 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2012 | 37 | 0.580 |
Why?
|
| Glucose | 2 | 2021 | 879 | 0.570 |
Why?
|
| Endocytosis | 4 | 2017 | 125 | 0.560 |
Why?
|
| Endotoxins | 1 | 2017 | 48 | 0.550 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 292 | 0.540 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 129 | 0.540 |
Why?
|
| PPAR gamma | 1 | 2017 | 88 | 0.540 |
Why?
|
| Animals | 32 | 2024 | 34046 | 0.510 |
Why?
|
| Retinal Neovascularization | 1 | 2015 | 14 | 0.510 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 60 | 0.500 |
Why?
|
| Retinal Vessels | 1 | 2015 | 73 | 0.480 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 241 | 0.480 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 483 | 0.470 |
Why?
|
| Cardiovascular System | 1 | 2015 | 105 | 0.450 |
Why?
|
| Homeostasis | 1 | 2018 | 685 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 2 | 2014 | 5 | 0.440 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 114 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2014 | 15 | 0.440 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2014 | 22 | 0.430 |
Why?
|
| Pneumonia | 1 | 2017 | 323 | 0.430 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2286 | 0.430 |
Why?
|
| Energy Metabolism | 1 | 2018 | 774 | 0.420 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2014 | 10 | 0.410 |
Why?
|
| Myocytes, Cardiac | 5 | 2022 | 603 | 0.390 |
Why?
|
| Mice | 20 | 2024 | 17625 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 4401 | 0.380 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 126 | 0.380 |
Why?
|
| Transfection | 5 | 2017 | 1062 | 0.380 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 113 | 0.370 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 221 | 0.360 |
Why?
|
| Inflammation | 3 | 2023 | 1428 | 0.360 |
Why?
|
| RNA Interference | 4 | 2017 | 498 | 0.340 |
Why?
|
| Apoptosis | 4 | 2017 | 1782 | 0.330 |
Why?
|
| Aortic Diseases | 1 | 2012 | 198 | 0.330 |
Why?
|
| Lung | 1 | 2017 | 1487 | 0.320 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 942 | 0.320 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 208 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2024 | 485 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2005 | 9 | 0.300 |
Why?
|
| Pseudopodia | 1 | 2007 | 7 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2007 | 409 | 0.290 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 219 | 0.290 |
Why?
|
| Myosins | 1 | 2007 | 46 | 0.290 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 240 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 37 | 0.280 |
Why?
|
| Cattle | 4 | 2014 | 565 | 0.280 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 2522 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1530 | 0.270 |
Why?
|
| Atherosclerosis | 2 | 2014 | 911 | 0.250 |
Why?
|
| Aorta | 2 | 2014 | 537 | 0.240 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 96 | 0.240 |
Why?
|
| Phenotype | 4 | 2017 | 4251 | 0.240 |
Why?
|
| Smad5 Protein | 1 | 2024 | 22 | 0.230 |
Why?
|
| Smad1 Protein | 1 | 2024 | 22 | 0.230 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 167 | 0.230 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 4344 | 0.230 |
Why?
|
| Vascular Remodeling | 1 | 2024 | 41 | 0.230 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 440 | 0.220 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2024 | 108 | 0.220 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2023 | 2 | 0.220 |
Why?
|
| Time Factors | 4 | 2017 | 6283 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 206 | 0.200 |
Why?
|
| Smegmamorpha | 1 | 2022 | 1 | 0.200 |
Why?
|
| Nitrates | 1 | 2002 | 28 | 0.200 |
Why?
|
| Fatty Acids | 2 | 2022 | 346 | 0.200 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 23 | 0.190 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 25 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 2392 | 0.190 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 78 | 0.180 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 90 | 0.180 |
Why?
|
| Humans | 19 | 2024 | 124240 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 93 | 0.180 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 42 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 67 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2017 | 427 | 0.180 |
Why?
|
| Osteoblasts | 1 | 2021 | 148 | 0.170 |
Why?
|
| Genes, Reporter | 1 | 2021 | 381 | 0.170 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2012 | 31 | 0.170 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 78 | 0.170 |
Why?
|
| Heart | 2 | 2015 | 708 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 390 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 149 | 0.170 |
Why?
|
| Oxygen | 2 | 2015 | 553 | 0.170 |
Why?
|
| Genotype | 3 | 2015 | 2556 | 0.170 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 1388 | 0.160 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 212 | 0.160 |
Why?
|
| Protein Binding | 3 | 2021 | 1738 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2015 | 238 | 0.160 |
Why?
|
| Hypoxia | 3 | 2015 | 248 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 292 | 0.160 |
Why?
|
| Cholesterol | 2 | 2023 | 536 | 0.160 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2024 | 88 | 0.150 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 35 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2018 | 79 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 130 | 0.150 |
Why?
|
| Heart Failure | 2 | 2023 | 2288 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 1696 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 324 | 0.140 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cadherins | 1 | 2018 | 166 | 0.140 |
Why?
|
| Leukocytes | 1 | 2018 | 204 | 0.140 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
| CD36 Antigens | 1 | 2017 | 37 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2015 | 1615 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 310 | 0.130 |
Why?
|
| Adipokines | 1 | 2017 | 58 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2021 | 1135 | 0.130 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 82 | 0.130 |
Why?
|
| Insulin | 1 | 2021 | 1200 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2815 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 354 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 97 | 0.130 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2015 | 22 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2015 | 800 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 94 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 49 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 258 | 0.120 |
Why?
|
| Mixed Function Oxygenases | 1 | 2015 | 30 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 78 | 0.120 |
Why?
|
| Male | 10 | 2024 | 61023 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 339 | 0.120 |
Why?
|
| Heart Valves | 1 | 2015 | 50 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 84 | 0.120 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 62 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2005 | 2582 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 680 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 79 | 0.120 |
Why?
|
| Isoindoles | 1 | 2014 | 3 | 0.120 |
Why?
|
| Organoselenium Compounds | 1 | 2014 | 5 | 0.120 |
Why?
|
| Neointima | 1 | 2015 | 43 | 0.120 |
Why?
|
| Azoles | 1 | 2014 | 9 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 213 | 0.110 |
Why?
|
| Weight Gain | 1 | 2017 | 404 | 0.110 |
Why?
|
| Cell Line | 3 | 2015 | 2747 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2014 | 72 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 325 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 158 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 513 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2014 | 229 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2014 | 99 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 146 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 660 | 0.110 |
Why?
|
| Myocardium | 2 | 2015 | 996 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 180 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2015 | 608 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2005 | 622 | 0.100 |
Why?
|
| DNA Damage | 2 | 2015 | 513 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 168 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 62 | 0.100 |
Why?
|
| Dioxygenases | 1 | 2012 | 47 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 137 | 0.100 |
Why?
|
| Rats | 5 | 2015 | 3676 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 1010 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 335 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 56 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 189 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cytokines | 1 | 2017 | 1289 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 209 | 0.090 |
Why?
|
| Interleukin-11 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1258 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 997 | 0.090 |
Why?
|
| Hindlimb | 1 | 2010 | 76 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2014 | 537 | 0.090 |
Why?
|
| Zebrafish | 1 | 2012 | 383 | 0.080 |
Why?
|
| Femoral Artery | 1 | 2010 | 194 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2007 | 1890 | 0.080 |
Why?
|
| Hydroxylation | 2 | 2021 | 45 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 1454 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2015 | 1231 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2007 | 10 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2007 | 44 | 0.070 |
Why?
|
| Ischemia | 1 | 2010 | 354 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2007 | 124 | 0.070 |
Why?
|
| Stem Cells | 2 | 2014 | 694 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3150 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2022 | 1006 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2006 | 194 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 95 | 0.060 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2004 | 38 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 112 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2004 | 94 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 141 | 0.060 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 4 | 0.060 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2003 | 3 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 22 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2003 | 43 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2024 | 60 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 453 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 37 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2004 | 163 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 132 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 85 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 256 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 44 | 0.050 |
Why?
|
| United States | 1 | 2018 | 10868 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 158 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 162 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2023 | 107 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2015 | 251 | 0.050 |
Why?
|
| Tropoelastin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Globins | 1 | 2002 | 35 | 0.050 |
Why?
|
| Gelsolin | 1 | 2002 | 13 | 0.050 |
Why?
|
| Nitroglycerin | 1 | 2002 | 22 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 259 | 0.050 |
Why?
|
| Respiration | 1 | 2022 | 120 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 217 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2002 | 255 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 177 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 87 | 0.050 |
Why?
|
| Cell Survival | 1 | 2003 | 806 | 0.050 |
Why?
|
| Carnitine | 1 | 2021 | 74 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 317 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2023 | 373 | 0.040 |
Why?
|
| Lysosomes | 2 | 2015 | 236 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 546 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1701 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2010 | 63 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1585 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 680 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 365 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 18 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 104 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2015 | 40 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 85 | 0.030 |
Why?
|
| Shear Strength | 1 | 2014 | 17 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 162 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 170 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 246 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 170 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 265 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2015 | 290 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 243 | 0.030 |
Why?
|
| Cell Division | 1 | 2015 | 776 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 406 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 460 | 0.030 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 96 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 169 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 135 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 332 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 107 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 806 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1560 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 436 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 325 | 0.020 |
Why?
|
| Clathrin | 1 | 2009 | 24 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 455 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 222 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 641 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 723 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 3089 | 0.020 |
Why?
|
| Female | 3 | 2023 | 66304 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 1318 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2004 | 5 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 882 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2006 | 338 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 143 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 862 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 529 | 0.010 |
Why?
|